:


Auerbuch SD, et al. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine and decarbazine. Ann Intern Med 109:267, 1988.

Bravo EL, et al. Clonidine suppression test: A useful aid in the diagnosis of pheochromocytoma. N Engl J Med 305:623, 1981.

Burgess GE III. Alpha blockade and surgical intervention of pheochro-mocytoma in pregnancy. Obstet Gynecol 53:266, 1979.

Cryer PE. Pheochromocytoma. J Clin Endocrinol Metab 14:203, 1985.

Dequattro V, et al. Pheochromocytoma: Diagnosis and therapy. In LJ DeGroot et al (eds), Endocrinology (2nd ed). Philadelphia: Saunders, 1989. Pp. 1780.

Israeli A, et al. Captopril and pheochromocytoma. Lancet 2:278, 1985.

Lloyd RV, et al. An immunohistochemical study of pheochromocytomas. Arc Pathol Lab Med 108:541, 1984.

Manger WM, Gifford RW, Jr. Pheochromocytoma. In JH Laragh, BM Brenner (eds), Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed). New York: Raven, 1990. Pp. 16399.

Moreau JP, Defeudis FV. Minireview-pharmacological studies of so- matostatin and somatostatin-analogues: Therapeutic advances and per- spectives. Life Sci 40:419, 1987.

Nicholas E, et al. Use of esmolol in the intraoperative management of pheochromocytoma. Anesth Analg 67:1114, 1988.

Nicholson JP, et al. Pheochromocytoma and prazocin. Ann Intern Med 99:477, 1983.

k , et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 134:315.

Oishi S, et al. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: Utility of 24-h and random 1-hour urine determination. J Clin Endocrinol Metab 67:614, 1981.

Quint LE, et al. Pheochromocytoma and paraganglioma: Comparison of MR imaging with CT and 1-131 M1BG scintigraphy. Radiology 165:89, 1987.

Rosca EA, et al. Treatment of pheochromocytoma and clonidine with-drawal hypertension with labetalol. Br J Clin Pharmacol 3:809, 1976.

Sawka AM, et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003; 88:553.

Serfas D, et al. Pheochromocytoma and hypertrophic cardiomyopathy: Apparent suppression of symptoms by calcium channel blockade. Lancet 2:711,1983.

Shapiro B, et al. Iodine-131-metaiodobenzylguanidine for the locating of suspected pheochromocytoma: Experience in 400 cases. J Nucl Med 26:576, 1985.

Sheps SG, et al. Diagnostic evaluation of pheochromocytoma Endocrinol Metab Clin North Am 17:397, 1988.

Sisson JC. Radiopharmaceutical treatment of pheochromocytomas. Ann NY Acad Sci 2002; 970:54.

Teply JJ, Lawrence GH. Pheochromocytoma. Am J Surg 140:107, 1980.

Walther MM. New therapeutic and surgical approaches to sporadic and hereditary pheochromocytoma. Ann NY Acad Sci 2002; 970:41.

Wheeler MH, et al. The association of neurofibromatosis pheochromocy-toma, and somatostatin-rich duodenal carcinoid tumor. Surge 100:1163, 1986.

: